Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
15.58
+1.11 (7.67%)
Aug 20, 2026, 3:04 PM CST
SHE:300401 Revenue
Zhejiang Garden Biopharmaceutical had revenue of 415.22M CNY in the quarter ending June 30, 2026, with 34.39% growth. This brings the company's revenue in the last twelve months to 1.29B, up 1.23% year-over-year. In the year 2025, Zhejiang Garden Biopharmaceutical had annual revenue of 1.24B, down -0.47%.
Revenue (ttm)
1.29B
Revenue Growth
+1.23%
P/S Ratio
6.55
Revenue / Employee
1.11M
Employees
1,163
Market Cap
8.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.24B | -5.88M | -0.47% |
| Dec 31, 2024 | 1.24B | 148.63M | 13.58% |
| Dec 31, 2023 | 1.09B | -322.86M | -22.78% |
| Jan 1, 2023 | 1.42B | 300.41M | 26.89% |
| Jan 1, 2022 | 1.12B | 457.66M | 69.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.